FDA grants breakthrough nod for water vapor ablation therapy from Francis Medical

Francis Medical’s cancer ablation device delivers water vapor that cools and kills cancer cells. [Image courtesy of Francis Medical]Francis Medical announced that the FDA granted breakthrough device designation for its Vanquish water vapor ablation therapy.

The Minneapolis-based company designed its proprietary, minimally invasive Vanquish therapy to treat prostate, kidney and bladder cancer.

Vanquish water vapor technology applies the thermal energy stored in drops of water to deliver targeted treatments to cancerous tissue. It takes place through a simple transurethral procedure. Francis Medical designed Vanquish to ablate cancer cells while protecting the surrounding structures. This lessens the likelihood of life-altering side effects that can come with other prostate cancer treatments.

Francis Medical remains in the process of initiating its VAPOR 2 pivotal study in support of submission for FDA clearance. The trial aims to treat 235 patients wit…

Read more
  • 0